Abstract 2063P
Background
In this study we seek to learn more about the lifestyle habits of our cancer patients, with a particular emphasis in exercise and eating behaviours. We choose to focus on these two areas as they have an outsized impact on clinical outcomes such as mortality, risk of relapse, quality of life, sarcopenia, duration of hospitalizations, post-surgical complications, response to immunotherapy and even overall survival rates.
Methods
Observational study across a cross-section of cancer patients at the Medical Oncology Service of the Nuestra Señora de Candelaria University Hospital, Santa Cruz de Tenerife. The statistical significance of lifestyle habit changes is tested through a form and IPAQ, MUST, and SARC-F surveys using chi-squared tests.
Results
We involved 100 patients whose average age was 61 years. 46% of patients had lung cancer, 30% breast cancer and 10% gastrointestinal cancer. 59% patients had stage-four cancer, 48% were receiving first-line treatment and 54% were being treated with immunotherapy or target therapies. 99% of individuals considered their diet as an important pillar in their cancer disease. However, we found that only 47% had discussed aspects of their nutrition with their oncologist, but this was not statistically associated with a reduced risk of malnutrition. 80% considered that a healthy lifestyle could help reduce the adverse effects of the treatment. The validated test results showed that 45% had an intermediate-high risk of malnutrition according to the MUST test and 14% had risk of sarcopenia according to the SARC-F test. Patients receiving immunotherapy or target therapies had a higher risk of malnutrition than those receiving other treatments (50 vs 42%, p=.507). 47% were sedentary according to the IPAQ test and 80% who did not perform physical activity would start an adapted exercise program if it were available.
Conclusions
Our patients present good high-level awareness about the generally positive ways in which lifestyle changes involving healthier eating and exercise habits can impact the outcome of their treatments. However, we appreciate a need for more specific nutritional and fitness recommendations that patients can immediately put into practice, as well their ranked impact on their health.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2106P - Safety and patient reported outcomes of SARS-CoV-2 vaccination in patients with cancer
Presenter: Amy Body
Session: Poster session 06
2107P - Thromboprophylaxis with intermediate or prophylactic doses of LMWHs in ambulatory cancer patients
Presenter: Nikolaos Tsoukalas
Session: Poster session 06
2108P - Vitamin B12 and its clinical relevance in hospitalized cancer patients
Presenter: Stefano Maccarone
Session: Poster session 06
2109P - Vitamin A, D and E levels in patients with solid tumors undergoing palliative systemic cancer treatment
Presenter: Julia Berger
Session: Poster session 06
2111P - The value of multiple psychometric tools for distress screening and referral in a cancer population
Presenter: Daniel Anderson
Session: Poster session 06
2112P - Initial geriatric assessment and chemotherapy tolerability treatment in Brazilian patients with malignant neoplasm of the digestive system
Presenter: Marcos Dumont Bonfin Santos
Session: Poster session 06
2113P - Efficacy and effectiveness of prophylactic magnesium supplementation on prevention of cisplatin-induced nephrotoxicity: A systematic review and meta-analysis
Presenter: Caio Castro
Session: Poster session 06
2114P - Impact of comprehensive geriatric assessment (CGA) in the management of chemotherapy toxicity in older cancer patients
Presenter: Jordi Recuero-Borau
Session: Poster session 06
2115P - Pre-cachexia incidence in patients with solid cancer: A cross-sectional study
Presenter: Lynn Gottmann
Session: Poster session 06